跳到正文
openFDA 已分级药品召回执法报告·· 8 天前精选AI 评分73

FDA 执法报告 D-0004-2027 记录 K.C. Pharmaceuticals 滴眼液无菌保证不足的 II 类召回

FDA drug enforcement D-0004-2027: K.C. Pharmaceuticals, Inc. — Lack of Assurance of Sterility

AI 导读

openFDA 执法报告 D-0004-2027 记录 K.C. Pharmaceuticals 因无菌保证不足自愿召回多品牌无菌滴眼液,FDA 将其列为 II 类。

推荐理由

记录列出无菌保证不足召回的类别、批次与全国分销范围,可用于核对同一事件下多品牌滴眼液的产品归属。

正文 · AI 翻译

FDA 药品召回执法报告 — D-0004-2027

报告发布日期:2026-10-14。这是执法报告日期,不是召回启动日期。

范围:一条已分类的药品召回记录;event_id 可能归组多个产品。没有召回编号的未分类记录不在本数据流范围内。本记录不是新闻稿,也不是新的执法认定。

openFDA 数据集每周更新。报告状态不是实时召回状态,不得用于跟踪召回生命周期。以下其他日期保留其各自名称所对应的含义。

完整官方产品记录(包括 openFDA 统一标识符):

{

"address_1": "3420 Pomona Blvd",

"address_2": "N/A",

"center_classification_date": "20261005",

"city": "Pomona",

"classification": "Class II",

"code_info": "Lot: a) AR25A02, Exp.: 1/1/2027; b) AR25A02, Exp.: 1/1/2027; c) AR25A01, Exp.: 1/1/2027; AR25N01, Exp.: 11/30/2027; d) AR25A02, Exp.: 1/1/2027; e) AR25A02, Exp.: 1/1/2027; f) AR25A02, Exp.: 1/1/2027; g) AR25F01, Exp.: 6/30/2027; AR25N01, Exp.: 11/30/2027; h) AR25A02, Exp.: 1/1/2027; I) AR25A01, Exp.: 1/1/2027; AR25N01, Exp.: 11/30/2027; J) AR25A01, Exp.: 1/1/2027.",

"country": "United States",

"distribution_pattern": "US Nationwide",

"event_id": "99880",

"initial_firm_notification": "E-Mail",

"openfda": {

"application_number": [

"M018"

],

"brand_name": [

"LEADER ADVANCED RELIEF EYE DROPS",

"GOODSENSE EYE DROPS ADVANCED RELIEF MOISTURIZER",

"MEDICS CHOICE EYE DROPS ADVANCED",

"FOSTER AND THRIVE ADVANCED RELIEF EYE DROPS",

"QUALITY CHOICE MOISTURIZING RELIEF EYE DROPS"

],

"generic_name": [

"DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL",

"DEXTRAN, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL",

"TETRAHYDROZOLINE HYDROCHLORIDE, POLYETHYLENE GLYCOL 400, DEXTRAN 70, POVIDONE",

"POLYETHYLENE GLYCOL 400, TETRAHYDROZOLINE HCL"

],

"is_original_packager": [

true

],

"manufacturer_name": [

"Cardinal Health",

"Geiss, Derstin & Dunn, Inc.",

"KC Pharmaceuticals, Inc.",

"Strategic Sourcing Services LLC",

"Chain Drug Marketing Association, Inc."

],

"nui": [

"N0000184175",

"N0000009361",

"N0000010288"

],

"package_ndc": [

"70000-0456-1",

"50804-130-01",

"55651-025-01",

"70677-1158-1",

"83324-191-14"

],

"pharm_class_epc": [

"Plasma Volume Expander [EPC]"

],

"pharm_class_moa": [

"Osmotic Activity [MoA]"

],

"pharm_class_pe": [

"Increased Intravascular Volume [PE]"

],

"product_ndc": [

"70000-0456",

"50804-130",

"55651-025",

"70677-1158",

"83324-191"

],

"product_type": [

"HUMAN OTC DRUG"

],

"route": [

"OPHTHALMIC"

],

"rxcui": [

"996202",

"996209"

],

"spl_id": [

"4ccce313-8eec-8a62-e063-6394a90aa128",

"47450d1c-db32-92cd-e063-6394a90a0703",

"4748d5b2-f2f1-e88b-e063-6394a90af39a",

"474922b2-773c-4cff-e063-6394a90a6b3a",

"4749597d-57d8-92b6-e063-6294a90ab574"

],

"spl_set_id": [

"5c5d6c13-9b51-48f0-8627-b60b0f707fd3",

"9b34de99-13df-201a-e053-2a95a90ae559",

"ab906fd8-265c-4359-a920-d626366e245c",

"0019cd99-b245-2ffc-e063-6294a90a9f27",

"1fb81759-5931-59c8-e063-6294a90a2277"

],

"substance_name": [

"DEXTRAN 70",

"POLYETHYLENE GLYCOL 400",

"POVIDONE",

"TETRAHYDROZOLINE HYDROCHLORIDE"

],

"unii": [

"7SA290YK68",

"B697894SGQ",

"FZ989GH94E",

"0YZT43HS7D"

],

"upc": [

"0096295136470",

"0180410000194",

"0095072012518",

"0010939958273",

"0635515903760",

"041163253926",

"041220437450",

"184125000180",

"041415067769",

"036800036413"

]

},

"postal_code": "91768-3236",

"product_description": "无菌滴眼液 Advanced Relief(dextran 70,0.1%,polyethylene glycol 400 1% 和 tetrahydrozoline HCl 0.05%),0.5 FL OZ(15 mL)瓶装,无菌;a) LEADER,DISTRIBUTED BY CARDINAL HEALTH,DUBLIN, OHIO 43017,www.myleader.com,NDC 70000-0456-1;b) Equaline,DISTRIBUTED BY: UNFI,PROVIDENCE, RI 02908 UPC 0 41163 25392 6;c) GoodSense,Distributed By: Geiss, Destin& Dunn, Inc.,A Perrigo Company,Peachtree City, GA 30269,www.PerrigoDirect.com,NDC 50804-130-01;d) H.E.B A.C. Eye Drops,MADE WITH PRIDE & CARE FOR H-E-B,SAN ANTONIO, TX 78204,UPC 0 41220 43745 0;e) Medic'c Choice,Manufactured by KC Pharmaceuticals, Inc.,Pomona, CA 91768,NDC 55651-025-01;f) Foster & Thrive,Distributed by: McKesson Corp.,via Strategic Sourcing Services LLC,Memphis, TN 38141,NDC 70677-1158-1;g) Colirio Manzanill A+,Distributed by: PRO-MEX,P.O Box 63-0716,Miami , FL 33163,UPC: 1 84125 00018 0;h) P,DISTRIBUTED BY PUBLIX SUPER MARKETS, INC,3300 PUBLIX CORPORATE PARKWAY,LAKELAND, FL 33811,UPC 0 41415 06776 9;I) QC-Quality Choice,Distributed by: CDMA, Inc.,Novi, MI 48375,NDC 83324-191-14;J) TopCare health,DISTRIBUTED BY TOPCO ASSOCIATES LLC,ELKGROVE VILLAGE, IL 60007,UPC 0 36800 03641 3。",

"product_quantity": "208,896 箱",

"product_type": "药品",

"reason_for_recall": "无菌性缺乏保证",

"recall_initiation_date": "20260911",

"recall_number": "D-0004-2027",

"recalling_firm": "K.C. Pharmaceuticals, Inc.",

"report_date": "20261014",

"state": "CA",

"status": "进行中",

"voluntary_mandated": "自愿:企业发起"

}

来源:openFDA 已分级药品召回执法报告 · api.fda.gov